Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, it offers maintenance services for medical equipment, as well as acceptance and specialist tests. The company was founded in 2001 and is based in Warsaw, Poland.
Frequently asked questions
What sector does Synektik S.A. (SNT) operate in?
Synektik S.A. belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Synektik S.A. (SNT) current stock price?
As of the latest data, Synektik S.A. stock price is PLN 362.00, with a previous close of PLN 361.60. Synektik S.A. gained PLN 0.40 in the last trading session, representing a 0.11% increase.
What is Synektik S.A. (SNT) current market capitalization?
Synektik S.A. market cap is approximately 3.09 billion.
What is Synektik S.A. (SNT) Earnings Per Share (EPS)?
The trailing EPS is PLN 18.03, and the forward EPS is PLN 19.70.
What is Synektik S.A. (SNT) Price-to-Earnings (P/E) ratio?
Synektik S.A. current P/E ratio is 20.08, with a forward P/E of 18.38.
What is Synektik S.A. (SNT) EBITDA?
Synektik S.A. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 58.34 million.
Does Synektik S.A. (SNT) pay dividends?
Yes. Synektik S.A. pays annual dividends with an annualized yield of 2.97% and an estimated annual payout of PLN 10.75 per share.
When is the next ex-dividend date for Synektik S.A. (SNT)?
The next ex-dividend date is scheduled for January 28, 2027.
What is Synektik S.A. (SNT) beta (volatility) score?
Synektik S.A. has a beta of 0.032, indicating lower volatility than the overall market.
